Ae1 Ae3 Antibody Bafilomycin A1 Bile Acid Assay Bioassay Blog cDNA Ch 223191 Choline Acetyltransferase Antibody Deoxycholic Acid Sodium Salt ELISA kit Epz 6438 Glycodeoxycholic Acid Hdac Activity Assay immune Isotype Ldn 193189 Medium Mip 1B Mmp Activity Assay Mothers Against Decapentaplegic Mouse Albumin Elisa Pamabrom 100Mg Pepstatin A peptide Phospho 4Ebp1 Polyclonal Purification Trypsin Activity Assay Tubastatin A Uric Acid Assay Valproic Acid Sodium Salt Western Blot
A framework for highly multiplexed dextramer mapping
A framework for extremely multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
T cell receptor (TCR) antigen-specific recognition is important for the adaptive immune system. Nonetheless, constructing a TCR-antigen interplay map has been difficult because of the staggering range of TCRs and antigens. Accordingly, extremely multiplexed dextramer-TCR binding assays have been lately developed, however the utility of the following giant datasets is proscribed by the dearth of strong computational strategies for normalization and interpretation.
Right here, we current a computational framework comprising a novel technique, ICON (Integrative COntext-specific Normalization), for figuring out dependable TCR-pMHC (peptide-major histocompatibility complicated) interactions and a neural network-based classifier TCRAI that outperforms different state-of-the-art strategies for TCR-antigen specificity prediction. We additional demonstrated that by combining ICON and TCRAI, we’re in a position to uncover novel subgroups of TCRs that bind to a given pMHC through completely different mechanisms. Our framework facilitates the identification and understanding of TCR-antigen-specific interactions for fundamental immunological analysis and scientific immune monitoring.
EBAG9 Antibody |
|||
| DF6703 | Affbiotech | 200ul | EUR 420 |
EBAG9 Antibody |
|||
| 1-CSB-PA007355GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against EBAG9. Recognizes EBAG9 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
EBAG9 antibody |
|||
| 70R-9916 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal EBAG9 antibody |
|||
EBAG9 Peptide |
|||
| 45-515P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: EBAG9 / RCAS1 Peptide |
|||
EBAG9 antibody |
|||
| 70R-16981 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal EBAG9 antibody |
|||
EBAG9 antibody |
|||
| 38323-100ul | SAB | 100ul | EUR 302.4 |
EBAG9 Antibody |
|||
| ABD6703 | Lifescience Market | 100 ug | EUR 525.6 |
EBAG9 siRNA |
|||
| 20-abx901624 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx914879 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx914880 | Abbexa |
|
|
EBAG9 Antibody |
|||
| R31790 | NSJ Bioreagents | 100 ug | EUR 419 |
EBAG9 Antibody |
|||
| R34393-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
CMV (Cytomegalovirus Antibody IgG) ELISA test |
|||
| 28 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG) |
|||
EBAG9 protein (His tag) |
|||
| 80R-1093 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human EBAG9 protein |
|||
ALS-Style Pucks (28) - Bulk Pricing Options |
|||
| M-CP-111-035-28 | MiTeGen | 14 PUCKS | EUR 8480 |
|
Description: ALS-Style Pucks (28) - Bulk Pricing Options |
|||
EBAG9 Rabbit pAb |
|||
| A8385-100ul | Abclonal | 100 ul | EUR 369.6 |
EBAG9 Rabbit pAb |
|||
| A8385-200ul | Abclonal | 200 ul | EUR 550.8 |
EBAG9 Rabbit pAb |
|||
| A8385-20ul | Abclonal | 20 ul | Ask for price |
EBAG9 Rabbit pAb |
|||
| A8385-50ul | Abclonal | 50 ul | Ask for price |
EBAG9 Blocking Peptide |
|||
| DF6703-BP | Affbiotech | 1mg | EUR 234 |
EBAG9 Conjugated Antibody |
|||
| C38323 | SAB | 100ul | EUR 476.4 |
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU1-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU2-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
Human EBAG9 Antibody |
|||
| 32605-05111 | AssayPro | 150 ug | EUR 313.2 |
EBAG9 Blocking Peptide |
|||
| 33R-2039 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EBAG9 antibody, catalog no. 70R-9916 |
|||
EBAG9 Rabbit pAb |
|||
| A1935-100ul | Abclonal | 100 ul | EUR 369.6 |
EBAG9 Rabbit pAb |
|||
| A1935-200ul | Abclonal | 200 ul | EUR 550.8 |
EBAG9 Rabbit pAb |
|||
| A1935-20ul | Abclonal | 20 ul | EUR 219.6 |
EBAG9 Rabbit pAb |
|||
| A1935-50ul | Abclonal | 50 ul | EUR 267.6 |
Anti-EBAG9 Antibody |
|||
| PB9553 | BosterBio | 100ug/vial | EUR 400.8 |
pCMV-SPORT6-EBAG9 |
|||
| PVT13493 | Lifescience Market | 2 ug | EUR 469.2 |
Anti-EBAG9 antibody |
|||
| STJ110683 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 antibody |
|||
| STJ23462 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 (4A10) |
|||
| YF-MA16699 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to EBAG9 |
|||
Recombinant HPV-28 E1 Protein |
|||
| VAng-Wyb3131-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Replication protein E1, recombinant protein. |
|||
Recombinant HPV-28 L1 Protein |
|||
| VAng-Wyb3136-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Major capsid protein L1, recombinant protein. |
|||
RNU6-28 Recombinant Protein (Human) |
|||
| RP089073 | ABM | 100 ug | Ask for price |
Human EBAG9 shRNA Plasmid |
|||
| 20-abx956064 | Abbexa |
|
|
Rat EBAG9 shRNA Plasmid |
|||
| 20-abx989010 | Abbexa |
|
|
Mouse EBAG9 shRNA Plasmid |
|||
| 20-abx974569 | Abbexa |
|
|
Polyclonal EBAG9 Antibody (Center) |
|||
| APR06938G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 Antibody (Center) |
|||
| APR04492G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Anti-EBAG9 / RCAS1 antibody |
|||
| STJ70947 | St John's Laboratory | 100 µg | EUR 430.8 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-100ug |
|||
| QP5959-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-10ug |
|||
| QP5959-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-1mg |
|||
| QP5959-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-200ug |
|||
| QP5959-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-500ug |
|||
| QP5959-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-50ug |
|||
| QP5959-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06871 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06872 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06873 | CHI Scientific | 1mg | Ask for price |
Matrix Metalloproteinase-28 (Recombinant) |
|||
| 20-abx073425 | Abbexa |
|
|
Recombinant Keratin 28 (KRT28) |
|||
| 4-RPS214Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Keratin 28 expressed in: E.coli |
|||
IL-28, human recombinant |
|||
| 4978-1000 | Biovision | each | EUR 6244.8 |
IL-28, human recombinant |
|||
| 4978-20 | Biovision | each | EUR 352.8 |
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013461 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013462 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013463 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013464 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013465 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013466 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013467 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013468 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV174238 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV174239 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV174240 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV174241 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPB-C-His) |
|||
| PV265294 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPB-N-His) |
|||
| PV265295 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV265296 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPM-C-His) |
|||
| PV265297 | ABM | 500 ng | EUR 723.6 |
Human EBAG9 Antibody (Biotin Conjugate) |
|||
| 32605-05121 | AssayPro | 150 ug | EUR 442.8 |
EBAG9 ELISA Kit (Human) (OKCA02302) |
|||
| OKCA02302 | Aviva Systems Biology | 96 Wells | EUR 1116 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: 0.195 U/mL. |
|||
Ebag9 ORF Vector (Rat) (pORF) |
|||
| ORF066324 | ABM | 1.0 ug DNA | EUR 607.2 |
EBAG9 ELISA Kit (Human) (OKEH05822) |
|||
| OKEH05822 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.39U/L |
|||
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003366 | ABM | 1.0 ug DNA | EUR 114 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003367 | ABM | 1.0 ug DNA | EUR 114 |
Ebag9 ORF Vector (Mouse) (pORF) |
|||
| ORF043560 | ABM | 1.0 ug DNA | EUR 607.2 |
Insulin R / CD220 (28-944) Recombinant Protein |
|||
| 11-371 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1. |
|||
PRSS28 Protease Serine 28 Mouse Recombinant Protein |
|||
| PROTQ924N9 | BosterBio | Regular: 5ug | EUR 380.4 |
|
Description: PRSS28 Mouse Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 256 amino acids (27-274a.a.) and having a molecular mass of 28.7kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa)._x000D_PRSS28 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
MMP28 Matrix Metalloproteinase-28 Human Recombinant Protein |
|||
| PROTQ9H239 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: MMP28 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 421 amino acids (123-520a.a) and having a molecular mass of 47.3kDa. MMP28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-100g | Creative Biolabs | 100 µg | EUR 1215.6 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-1mg | Creative Biolabs | 1 mg | EUR 7682.4 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-20g | Creative Biolabs | 20 µg | EUR 712.8 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-50g | Creative Biolabs | 50 µg | EUR 1215.6 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-100g | Creative Biolabs | 100 µg | EUR 8704.8 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-50g | Creative Biolabs | 50 µg | EUR 5718 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-100g | Creative Biolabs | 100 µg | EUR 1380 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-1mg | Creative Biolabs | 1 mg | EUR 4695.6 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-500g | Creative Biolabs | 500 µg | EUR 3195.6 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-1mg | Creative Biolabs | 1 mg | EUR 4068 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-200g | Creative Biolabs | 200 µg | EUR 1644 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-500g | Creative Biolabs | 500 µg | EUR 2667.6 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-1mg | Creative Biolabs | 1 mg | EUR 7022.4 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-500g | Creative Biolabs | 500 µg | EUR 4299.6 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-500g | Creative Biolabs | 500 µg | EUR 7698 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-50g | Creative Biolabs | 50 µg | EUR 1495.2 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3092.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2096.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1436.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
VPS28 Vacuolar Protein Sorting 28 Human Recombinant Protein |
|||
| PROTQ9UK41 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: VPS28 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 221 amino acids (1-221 a.a.) and having a molecular mass of 25.4kDa.;The VPS28 is purified by proprietary chromatographic techniques. |
|||
Prefilled 2.0ml tubes |
|||
| D1033-28 | Benchmark Scientific | 1 PC | EUR 215.81 |
Prefilled 5.0ml tubes |
|||
| D1034-28 | Benchmark Scientific | 1 PC | EUR 285.76 |
Bulk Beads |
|||
| D1133-28 | Benchmark Scientific | 1 PC | EUR 112.45 |
Anti-Histone H3 pan Rabbit Monoclonal Antibody, Clone#RM188 |
|||
| M06819-28 | BosterBio | 100ug | EUR 561.6 |
|
Description: Anti-Histone H3 pan Rabbit Monoclonal Antibody, Clone#RM188 tested in WB, ELISA, Multiplex, ICC, reactive to All Vertebrates |
|||
IL-17, Interleukin-17 IL-17A, human |
|||
| RC212-28 | Bio Basic | 5ug | EUR 125.26 |
TARC, CCL17, human |
|||
| RC315-28 | Bio Basic | 5ug | EUR 125.26 |
TARC, CCL17, murine (mouse) |
|||
| RC335-28 | Bio Basic | 5ug | EUR 125.26 |
VCC-1, CXCL17, rat |
|||
| RC352-28 | Bio Basic | 2ug | EUR 125.26 |
Somatostatin-28 |
|||
| 5-01950 | CHI Scientific | 0.4 x 5mg | Ask for price |
SMER 28 |
|||
| B7637-10 | ApexBio | 10 mg | EUR 226.8 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
SMER 28 |
|||
| B7637-50 | ApexBio | 50 mg | EUR 762 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
WRG-28 |
|||
| HY-114169 | MedChemExpress | 1mg | EUR 129.6 |
Somatostatin-28 |
|||
| H-4955.0500 | Bachem | 0.5mg | EUR 471.6 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
Somatostatin-28 |
|||
| H-4955.1000 | Bachem | 1.0mg | EUR 835.2 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
28-Deoxonimbolide |
|||
| TBZ1212 | ChemNorm | unit | Ask for price |
Vacuolar Protein Sorting 28 Protein |
|||
| 20-abx260470 | Abbexa |
|
|
Human EBAG9 AssayLite Antibody (FITC Conjugate) |
|||
| 32605-05141 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (RPE Conjugate) |
|||
| 32605-05151 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (APC Conjugate) |
|||
| 32605-05161 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (PerCP Conjugate) |
|||
| 32605-05171 | AssayPro | 150 ug | EUR 565.2 |
Polyclonal Goat Anti-EBAG9 / RCAS1 Antibody |
|||
| APG00095G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-EBAG9 / RCAS1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 / RCAS1 Antibody (C-Terminus) |
|||
| APG01031G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human EBAG9 / RCAS1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
EBAG9 sgRNA CRISPR Lentivector set (Human) |
|||
| K0649501 | ABM | 3 x 1.0 ug | EUR 406.8 |
Ebag9 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4445001 | ABM | 3 x 1.0 ug | EUR 406.8 |
Ebag9 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7421201 | ABM | 3 x 1.0 ug | EUR 406.8 |
TRIM28 Tripartite Motif Containing 28 Human Recombinant Protein |
|||
| PROTQ13263 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: TRIM28 Human Recombinant produced in E. Coli is a single polypeptide chain containing 460 amino acids (366-802) and having a molecular mass of 48.7 kDa.;TRIM28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant ALCAM Protein (Trp 28-Ala 526) [Fc] |
|||
| VAng-0714Lsx-1mg | Creative Biolabs | 1 mg | EUR 3294 |
|
Description: Human ALCAM, Fc tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001618) |
|||
Recombinant ALCAM Protein (Trp 28-Ala 526) [Fc] |
|||
| VAng-0714Lsx-200g | Creative Biolabs | 200 µg | EUR 951.6 |
|
Description: Human ALCAM, Fc tag, is expressed in HEK 293 cells. (Uniprot ID: NP_001618) |
|||
Recombinant ALCAM Protein (Trp 28-Ala 526) [His] |
|||
| VAng-0715Lsx-1mg | Creative Biolabs | 1 mg | EUR 3096 |
|
Description: Human ALCAM, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q13740-1) |
|||
Recombinant ALCAM Protein (Trp 28-Ala 526) [His] |
|||
| VAng-0715Lsx-200g | Creative Biolabs | 200 µg | EUR 885.6 |
|
Description: Human ALCAM, His tag, is expressed in HEK 293 cells. (Uniprot ID: Q13740-1) |
|||
Recombinant CD31 Protein (Gln 28-Lys 601) [Fc] |
|||
| VAng-1265Lsx-1mg | Creative Biolabs | 1 mg | EUR 4810.8 |
|
Description: Human CD31, Fc tag, is expressed in HEK 293 cells. (Uniprot ID: AAH22512.1) |
|||
Recombinant CD31 Protein (Gln 28-Lys 601) [Fc] |
|||
| VAng-1265Lsx-200g | Creative Biolabs | 200 µg | EUR 1182 |
|
Description: Human CD31, Fc tag, is expressed in HEK 293 cells. (Uniprot ID: AAH22512.1) |
|||
Recombinant CD31 Protein (Gln 28-Lys 601) [His] |
|||
| VAng-1266Lsx-100g | Creative Biolabs | 100 µg | EUR 885.6 |
|
Description: Human CD31, His tag, is expressed in HEK 293 cells. (Uniprot ID: P16284-1) |
|||
Recombinant CD31 Protein (Gln 28-Lys 601) [His] |
|||
| VAng-1266Lsx-1mg | Creative Biolabs | 1 mg | EUR 4810.8 |
|
Description: Human CD31, His tag, is expressed in HEK 293 cells. (Uniprot ID: P16284-1) |
|||
Recombinant CNDP1 Protein (Ser 28-His 508) [His] |
|||
| VAng-1408Lsx-1mg | Creative Biolabs | 1 mg | EUR 6328.8 |
|
Description: Human CNDP1, His tag, is expressed in HEK 293 cells. (Uniprot ID: AAI17123) |
|||
Recombinant CNDP1 Protein (Ser 28-His 508) [His] |
|||
| VAng-1408Lsx-50g | Creative Biolabs | 50 µg | EUR 1017.6 |
|
Description: Human CNDP1, His tag, is expressed in HEK 293 cells. (Uniprot ID: AAI17123) |
|||
Recombinant ErbB3 Protein (Leu 28-Gly 232) [His] |
|||
| VAng-1507Lsx-200g | Creative Biolabs | 200 µg | EUR 4612.8 |
|
Description: Human ErbB3 (Her3), His tag, is expressed in HEK 293 cells. (Uniprot ID: NP_004420) |
|||
Recombinant ErbB3 Protein (Leu 28-Gly 232) [His] |
|||
| VAng-1507Lsx-25g | Creative Biolabs | 25 µg | EUR 1215.6 |
|
Description: Human ErbB3 (Her3), His tag, is expressed in HEK 293 cells. (Uniprot ID: NP_004420) |
|||
Recombinant HAdV-12 PX Protein (aa 28-42) |
|||
| VAng-Cr4230-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2782.8 |
|
Description: HAdV-12 Late L2 mu core protein (PX), recombinant protein. |
|||
Recombinant HAdV-12 PX Protein (aa 28-42) |
|||
| VAng-Cr4230-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1990.8 |
|
Description: HAdV-12 Late L2 mu core protein (PX), recombinant protein. |
|||
Recombinant HAdV-12 PX Protein (aa 28-42) |
|||
| VAng-Cr4230-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1396.8 |
|
Description: HAdV-12 Late L2 mu core protein (PX), recombinant protein. |
|||
Recombinant Klebsiella Pneumoniae dsbL Protein (aa 28-222) |
|||
| VAng-Cr4770-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4134 |
|
Description: Klebsiella Pneumoniae Thiol:disulfide interchange protein DsbA-like (dsbL), recombinant protein. |
|||
Recombinant Klebsiella Pneumoniae dsbL Protein (aa 28-222) |
|||
| VAng-Cr4770-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2947.2 |
|
Description: Klebsiella Pneumoniae Thiol:disulfide interchange protein DsbA-like (dsbL), recombinant protein. |
|||
Recombinant Klebsiella Pneumoniae dsbL Protein (aa 28-222) |
|||
| VAng-Cr4770-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2007.6 |
|
Description: Klebsiella Pneumoniae Thiol:disulfide interchange protein DsbA-like (dsbL), recombinant protein. |
|||
Recombinant Pasteurella Multocida ahpA Protein (aa 28-226) |
|||
| VAng-Cr6697-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4167.6 |
|
Description: Pasteurella Multocida (strain Pm70) Protein AhpA (ahpA), recombinant protein. |
|||
Recombinant Pasteurella Multocida ahpA Protein (aa 28-226) |
|||
| VAng-Cr6697-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2980.8 |
|
Description: Pasteurella Multocida (strain Pm70) Protein AhpA (ahpA), recombinant protein. |
|||
Recombinant Pasteurella Multocida ahpA Protein (aa 28-226) |
|||
| VAng-Cr6697-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2023.2 |
|
Description: Pasteurella Multocida (strain Pm70) Protein AhpA (ahpA), recombinant protein. |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-1mg | Creative Biolabs | 1 mg | EUR 2997.6 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-200g | Creative Biolabs | 200 µg | EUR 1099.2 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-500g | Creative Biolabs | 500 µg | EUR 2040 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-526) [Fc] |
|||
| VAng-2953Lsx-10g | Creative Biolabs | 10 µg | EUR 390 |
|
Description: Recombinant Human ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-526) [Fc] |
|||
| VAng-2953Lsx-50g | Creative Biolabs | 50 µg | EUR 621.6 |
|
Description: Recombinant Human ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q13740) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-1mg | Creative Biolabs | 1 mg | EUR 3210 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-200g | Creative Biolabs | 200 µg | EUR 1182 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-500g | Creative Biolabs | 500 µg | EUR 2188.8 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-1mg | Creative Biolabs | 1 mg | EUR 7186.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-500g | Creative Biolabs | 500 µg | EUR 4546.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-50g | Creative Biolabs | 50 µg | EUR 2997.6 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Quantifying persistence within the T-cell signaling community utilizing an optically controllable antigen receptor
T cells discriminate between wholesome and contaminated cells with outstanding sensitivity when mounting an immune response, which is hypothesized to rely upon T cells combining stimuli from a number of antigen-presenting cell interactions right into a stronger response. To quantify the capability for T cells to perform this, now we have developed an antigen receptor that’s optically tunable inside cell conjugates, offering management over the period, and depth of intracellular T-cell signaling.
We observe restricted persistence throughout the T-cell intracellular community on disruption of receptor enter, with alerts dissipating completely in ~15 min, and straight present sustained proximal receptor signaling is required to keep up gene transcription. T cells thus primarily accumulate the outputs of gene expression slightly than combine discrete intracellular alerts. Engineering optical management in a clinically related chimeric antigen receptor (CAR), we present that this restricted sign persistence might be exploited to extend CAR-T cell activation threefold utilizing pulsatile stimulation. Our outcomes are prone to apply extra typically to the signaling dynamics of different mobile networks.
Tumor rejection properties of gp100 209-specific T cells correlate with T cell receptor binding affinity in the direction of the wild kind slightly than anchor-modified antigen
Though there are exceptions and outliers, T cell practical responses typically correlate with the affinity of a TCR for a peptide/MHC complicated. In a single lately described outlier case, probably the most promising scientific candidate in a collection of TCRs particular for the gp100209 melanoma antigen sure with the weakest answer affinity and produced the least quantity of cytokine in vitro. Hypotheses for this outlier habits included uncommon cytokine expression patterns arising from an atypical TCR binding geometry. Finding out this occasion in additional element, we discovered right here that outlier habits is attributable to not uncommon cytokine patterns or TCR binding, however using a place 2 anchor-modified peptide variant in in vitro experiments as a substitute of the wild kind antigen that’s current in vivo.
Though the anchor-modified variant has been extensively utilized in fundamental and scientific immunology as a surrogate for the wild kind peptide, prior work has proven that TCRs can clearly distinguish between the 2. We present that when this differential recognition is accounted for, the practical properties of gp100209-specific TCRs monitor with their affinity in the direction of the peptide/MHC complicated. Past demonstrating the correlates with T cell operate for a clinically related TCR, our outcomes present vital concerns for collection of TCRs for immunotherapy and using modified peptides in immunology.
Proliferating cell nuclear antigen straight interacts with androgen receptor and enhances androgen receptor‑mediated signaling
Androgen receptor (AR) and/or its constitutively lively splicing variants (AR‑Vs), resembling AR‑V7 and ARv567es, is required for prostate most cancers cell development and survival, and most cancers development. Proliferating cell nuclear antigen (PCNA) is preferentially overexpressed in all cancers and executes its features by interplay with quite a few accomplice proteins. The intention of the current research was to analyze the potential position of PCNA within the regulation of AR exercise.
An an identical consensus sequence of the PCNA‑interacting protein‑field (PIP‑field) was recognized on the N‑terminus of human, mouse and rat AR proteins. It was discovered that PCNA complexes with the total‑size AR (AR‑FL) and AR‑V7, which might be attenuated by the small molecule PIP‑field inhibitor, T2AA. PCNA additionally complexes with ARv567es and recombinant AR protein. The PCNA inhibitors, PCNA‑I1S and T2AA, inhibited AR transcriptional exercise and the expression of AR goal genes in LNCaP‑AI and 22Rv1 cells, however not in AR‑unfavorable PC‑three cells. The knockdown of PCNA expression lowered dihydrotestosterone‑stimulated AR transcriptional exercise and abolished the inhibitory impact of PCNA‑I1S on AR exercise. The PCNA inhibitor, PCNA‑I1, exerted additive development inhibitory results with androgen deprivation and enzalutamide in cells expressing AR‑FL or AR‑FL/AR‑V7, however not in AR‑unfavorable PC‑three cells.
Lastly, R9‑AR‑PIP, a small peptide mimicking AR PIP‑field, was discovered to bind to GFP‑PCNA at Okayd of two.73 µM and inhibit the expression of AR goal genes, AR transcriptional exercise and the expansion of AR‑expressing cells. On the entire, these information strongly counsel that AR is a PCNA accomplice protein and interacts with PCNA through the PIP‑field and that concentrating on the PCNA‑AR interplay could signify an revolutionary and selective therapeutic technique towards prostate most cancers, significantly castration‑resistant prostate cancers overexpressing constitutively lively AR‑Vs.
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells successfully remove human glioblastoma
Aims: The growing success of Chimeric Antigen Receptor (CAR) T cell remedy in haematological malignancies is reinvigorating its utility in lots of different most cancers sorts and with renewed deal with its utility to stable tumors. We current a novel CAR towards glioblastoma, an aggressive, malignant glioma, with a dismal survival charge for which remedy choices have remained unchanged for over a decade.
Strategies: We use the human Retained Show (ReD) antibody platform (Myrio Therapeutics) to determine a novel single-chain variable fragment (scFv) that recognises epidermal development issue receptor mutant variant III (EGFRvIII), a typical and tumor-specific mutation present in glioblastoma. We use each in vitro practical assays and an in vivo orthotopic xenograft mannequin of glioblastoma to look at the operate of our novel CAR, known as GCT02, focused utilizing murine CAR T cells.
Outcomes: Our EGFRvIII-specific scFv was discovered to be of a lot increased affinity than reported comparators reverse-engineered from monoclonal antibodies. Regardless of the upper affinity, GCT02 CAR T cells kill equivalently however secrete decrease quantities of cytokine. As well as, GCT02-CAR T cells additionally mediate fast and full tumor elimination in vivo.
Conclusion: We current a novel EGFRvIII-specific CAR, with efficient antitumor features each in in vitro and in a xenograft mannequin of human glioblastoma.
ZDHHC8P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701071 | ABM | 1.0 ug DNA | EUR 540 |
FLJ26850 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701077 | ABM | 1.0 ug DNA | EUR 540 |
OCLM Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701083 | ABM | 1.0 ug DNA | EUR 540 |
LINC00314 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701089 | ABM | 1.0 ug DNA | EUR 540 |
GSTTP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701095 | ABM | 1.0 ug DNA | EUR 540 |
LOC285679 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701101 | ABM | 1.0 ug DNA | EUR 540 |
VN1R3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701107 | ABM | 1.0 ug DNA | EUR 540 |
MT1DP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701119 | ABM | 1.0 ug DNA | EUR 540 |
LINC00313 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701131 | ABM | 1.0 ug DNA | EUR 540 |
LOC222699 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701143 | ABM | 1.0 ug DNA | EUR 540 |
LINC00161 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701149 | ABM | 1.0 ug DNA | EUR 540 |
LOC440419 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701155 | ABM | 1.0 ug DNA | EUR 540 |
KCNQ1DN Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701161 | ABM | 1.0 ug DNA | EUR 540 |
RBMS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701179 | ABM | 1.0 ug DNA | EUR 540 |
MIR22HG Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701185 | ABM | 1.0 ug DNA | Ask for price |
C22orf34 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701191 | ABM | 1.0 ug DNA | EUR 540 |
ZNF663 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701197 | ABM | 1.0 ug DNA | EUR 540 |
AKR1CL1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701203 | ABM | 1.0 ug DNA | EUR 540 |
HMGB3P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701209 | ABM | 1.0 ug DNA | EUR 540 |
ASIP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701215 | ABM | 1.0 ug DNA | EUR 540 |
LOC149950 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701221 | ABM | 1.0 ug DNA | EUR 540 |
BOLA2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701227 | ABM | 1.0 ug DNA | EUR 540 |
LOC441108 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701233 | ABM | 1.0 ug DNA | EUR 540 |
FLJ16126 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701239 | ABM | 1.0 ug DNA | EUR 540 |
LOC728032 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701245 | ABM | 1.0 ug DNA | EUR 540 |
C21orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701257 | ABM | 1.0 ug DNA | EUR 540 |
TP53TG3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701263 | ABM | 1.0 ug DNA | EUR 540 |
OSTBETA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701269 | ABM | 1.0 ug DNA | EUR 540 |
FLJ33360 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701275 | ABM | 1.0 ug DNA | EUR 540 |
LOC441208 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701281 | ABM | 1.0 ug DNA | EUR 540 |
C12orf36 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701287 | ABM | 1.0 ug DNA | EUR 540 |
LOC153684 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701293 | ABM | 1.0 ug DNA | EUR 540 |
LOC399900 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701299 | ABM | 1.0 ug DNA | EUR 540 |
LOC149134 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701305 | ABM | 1.0 ug DNA | EUR 540 |
LINC00173 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701317 | ABM | 1.0 ug DNA | EUR 540 |
LITAF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701323 | ABM | 1.0 ug DNA | EUR 540 |
HIST1H2AI Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701329 | ABM | 1.0 ug DNA | EUR 540 |
LOC440905 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701335 | ABM | 1.0 ug DNA | EUR 540 |
LOC339535 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701341 | ABM | 1.0 ug DNA | EUR 540 |
LOC643210 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701347 | ABM | 1.0 ug DNA | EUR 540 |
LOC440337 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701353 | ABM | 1.0 ug DNA | EUR 540 |
BEX1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701359 | ABM | 1.0 ug DNA | EUR 540 |
HIST2H2AA4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701365 | ABM | 1.0 ug DNA | EUR 540 |
LPAL2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701371 | ABM | 1.0 ug DNA | EUR 540 |
LOC340094 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701377 | ABM | 1.0 ug DNA | EUR 540 |
LINC00574 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701383 | ABM | 1.0 ug DNA | EUR 540 |
CIB2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701389 | ABM | 1.0 ug DNA | EUR 540 |
SNX12 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701401 | ABM | 1.0 ug DNA | EUR 540 |
FLJ44006 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701407 | ABM | 1.0 ug DNA | EUR 540 |
C15orf37 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701413 | ABM | 1.0 ug DNA | EUR 540 |
PLAC2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701419 | ABM | 1.0 ug DNA | EUR 540 |
BTG2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701425 | ABM | 1.0 ug DNA | EUR 540 |
FLJ40448 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701449 | ABM | 1.0 ug DNA | EUR 540 |
CIB3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701455 | ABM | 1.0 ug DNA | EUR 540 |
PRDX5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701461 | ABM | 1.0 ug DNA | EUR 540 |
FLJ45256 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701467 | ABM | 1.0 ug DNA | EUR 540 |
C21orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701473 | ABM | 1.0 ug DNA | EUR 540 |
LINC00477 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701479 | ABM | 1.0 ug DNA | EUR 540 |
LOC348262 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701491 | ABM | 1.0 ug DNA | EUR 540 |
SHISA4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701497 | ABM | 1.0 ug DNA | EUR 540 |
LOC400707 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701503 | ABM | 1.0 ug DNA | EUR 540 |
FLJ41423 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701509 | ABM | 1.0 ug DNA | EUR 540 |
FLJ46257 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701515 | ABM | 1.0 ug DNA | EUR 540 |
FKSG83 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701521 | ABM | 1.0 ug DNA | EUR 540 |
FLJ25328 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701527 | ABM | 1.0 ug DNA | EUR 540 |
LOC84931 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701533 | ABM | 1.0 ug DNA | EUR 540 |
LOC389791 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701539 | ABM | 1.0 ug DNA | EUR 540 |
LOC338809 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701545 | ABM | 1.0 ug DNA | EUR 540 |
LOC441251 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701557 | ABM | 1.0 ug DNA | EUR 540 |
INSL6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701563 | ABM | 1.0 ug DNA | EUR 540 |
C1orf222 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701569 | ABM | 1.0 ug DNA | EUR 540 |
SFTPA2B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701575 | ABM | 1.0 ug DNA | EUR 540 |
CCDC102B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701599 | ABM | 1.0 ug DNA | EUR 540 |
C1QTNF3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701605 | ABM | 1.0 ug DNA | EUR 540 |
OTOGL Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701611 | ABM | 1.0 ug DNA | EUR 540 |
LHPP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701617 | ABM | 1.0 ug DNA | EUR 540 |
TICAM2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701623 | ABM | 1.0 ug DNA | EUR 540 |
CHMP4A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701629 | ABM | 1.0 ug DNA | EUR 540 |
ALKBH3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701635 | ABM | 1.0 ug DNA | EUR 540 |
FBP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701641 | ABM | 1.0 ug DNA | EUR 540 |
CLEC12A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701647 | ABM | 1.0 ug DNA | EUR 540 |
OR2C1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701653 | ABM | 1.0 ug DNA | EUR 540 |
TMEM182 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701659 | ABM | 1.0 ug DNA | EUR 540 |
LOC339524 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701665 | ABM | 1.0 ug DNA | EUR 540 |
SEPSECS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701671 | ABM | 1.0 ug DNA | EUR 540 |
Selv Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701677 | ABM | 1.0 ug DNA | EUR 540 |
GPR87 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701683 | ABM | 1.0 ug DNA | EUR 540 |
ASTN2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701689 | ABM | 1.0 ug DNA | EUR 540 |
MAGEB3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701695 | ABM | 1.0 ug DNA | EUR 540 |
SSTr4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701713 | ABM | 1.0 ug DNA | EUR 540 |
